Clinical Trial Update: Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study [EARLY_Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 pilot study evaluating ThorS-MagNT magnetic neuromodulation therapy for grade 3 diabetic gastroparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Snippet

Sponsor: Augusta University | Conditions: Diabetic Gastroparesis | EARLY_Phase 1 | Status: COMPLETED